The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.
Daniel Dowd, PharmD
Advertisement
Articles by Daniel Dowd, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial
3
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures
4
Contextualizing Golcadomide's Efficacy Signal in the RRFL Landscape
5